Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Sell
14,349
-53,959
-79% -$4.94M 0.09% 93
2025
Q4
$6.03M Buy
+68,308
New +$6.22M 0.42% 52
2024
Q2
Sell
-169,919
Closed -$12.2M 84
2024
Q1
$12.2M Buy
+169,919
New +$12.2M 1.51% 19
2021
Q2
Sell
-215,886
Closed -$14.3M 141
2021
Q1
$14.3M Sell
215,886
-73,512
-25% -$4.57M 2.94% 8
2020
Q4
$18.4M Buy
+289,398
New +$18.6M 3.96% 8
2018
Q4
Sell
-173,436
Closed -$9.86M 22
2018
Q3
$9.86M Buy
+173,436
New +$10M 4.71% 11

Other funds holding SRE

Covalis Capital's SRE Position: Q1 2026 in Review

Covalis Capital reduced its Sempra (SRE) stake by 79% in Q1 2026, selling an estimated $4.94M and leaving 14,349 shares worth $1.39M. The position accounts for 0.09% of the portfolio, ranked #93.

Covalis Capital first reported a position in SRE in Q3 2018 and has held it in 6 quarters since. The position peaked at $18.4M in Q4 2020. 1,264 funds tracked by Wall St. Rank hold SRE as of Q1 2026.

  • Covalis Capital held 14,349 shares of Sempra worth $1.39M as of Q1 2026.
  • Covalis Capital sold 53,959 Sempra shares in Q1 2026, an estimated $4.94M.
  • Sempra made up 0.09% of Covalis Capital's portfolio in Q1 2026, its #93 holding.
  • Covalis Capital first reported a position in Sempra in Q3 2018 and has held it in 6 quarters since.
  • Covalis Capital's Sempra position peaked at $18.4M in Q4 2020.
  • 1,264 funds tracked by Wall St. Rank held Sempra as of Q1 2026.

Based on Covalis Capital's 13F filing for Q1 2026, filed 15 May 2026.